Buy Lucetam coated tablets 800mg №30
  • Buy Lucetam coated tablets 800mg №30

Lucetam pills 800mg №30


  • All payments are encrypted via SSL All payments are encrypted via SSL
  • Full Refund if you haven't received your order Full Refund if you haven't received your order

Lucetam/ Lucetam

Composition and release form

Lucetam - coated tablets: 1 table. contains Piracetam 400, 800 and 1200 mg; excipients: Magnesium stearate; Povidone K-30; macrogol 6000; dibutyl sebacate; titanium dioxide (E171); talc; ethyl cellulose; hypromellose; Pack of 60, 30, or 20 pieces;

Lucetam - solution for intravenous and intramuscular administration: 1 ml contains piracetam 200 mg; excipients: sodium acetate; glacial acetic acid; water for injections; in 5 or 15 ml ampoules; in a pack of cardboard 10 (5 ml) or 4 and 20 (15 ml) ampoules, respectively.

pharmachologic effect

Lucetam has a nootropic effect.


Symptomatic treatment of psychoorganic syndrome, in particular in elderly patients suffering from decreased memory, concentration and general activity, dizziness, mood changes, behavior disorders, gait disturbances, as well as in patients with Alzheimer's disease and senile dementia of the Alzheimer's type.

Treatment of the consequences of ischemic stroke, such as speech disorders, disorders of the emotional sphere, motor and mental activity.

Chronic alcoholism - for the treatment of psycho-organic and withdrawal syndromes.

During the recovery period after injuries and intoxications of the brain.

Treatment of vertigo and related balance disorders, with the exception of vertigo of mental origin.

As part of a complex therapy of low learning in children, especially in the case of difficulty in acquiring specific reading, writing, and counting skills that cannot be explained by mental retardation, inadequate instruction, or a peculiarity of the family environment.

For the treatment of cortical myoclonus as a mono-or complex therapy.


Hypersensitivity to piracetam or a derivative of pyrrolidone, as well as to other components of Lucetam; hemorrhagic stroke; end-stage renal failure (Cl creatinine 1%), increased irritability (> 1%), drowsiness (